Physician
Pathology
Dr. Frederick L. Baehner, MD
|
|
Give Review
Frederick L. Baehner, MD works in the field of Pathology. He went to University of Kansas School of Medicine. Dr. Frederick L. Baehner is a published doctor and has 48 publications published. The lastest was: 'A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling.' Dr. Frederick L. Baehner accepts Medicare payments and is listed with Medicare.gov.
Publications
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling.
- Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
- A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
- Elevated Levels of Proliferating and Recently Migrated Tumor-associated Macrophages Confer Increased Aggressiveness and Worse Outcomes in Breast Cancer.
- Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
- Morphometic Analysis of TCGA Glioblastoma Multiforme.
- Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Ca...
- The Impact of Primary Melanoma Thickness and Microscopic Tumor Burden in Sentinel Lymph Nodes on Melanoma Patient Survival.
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer.
- Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer.
- Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
- Biologic markers determine both the risk and the timing of recurrence in breast cancer.
- Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
- Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription po...
- Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery ...
- Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with ...
- Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture.
- Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
- A multimarker prognostic assay for primary cutaneous melanoma.
- The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.
- Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.
- Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
- Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription po...
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
- Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
- Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
- Genes and pathways downstream of telomerase in melanoma metastasis.
- Fine needle aspiration cytology of adult perineal rhabdomyosarcoma: a case report.
- Metastatic balloon cell melanoma: a case report.
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
- The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.
- Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study.
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemothe...
- The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
- Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
- Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
- Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cu...
- Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
- Breast cancer growth prevention by statins.
- Bladder cancer outcome and subtype classification by gene expression.
- Fine needle aspiration cytology of intraoral epithelioid hemangioma. A report of two cases.
- Breast cancer prognostic classification in the molecular era: the role of histological grade.
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
- Rt-PCR gene expression profiling of RNA from paraffin-embedded tissues prepared using a range of different fixatives and conditions.
- The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.
- Fetal neurenteric cyst causing hydrops: case report and review of the literature.
Schools
University of Kansas School of Medicine
University Ca Sf School Of Med
Doctors Specialties
- Cytopathology
- Pathology
Accepted Insurances
Education
-
UCSF -
University of Kansas School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326091208 |
| Last Name Of The Provider | BAEHNER |
| First Name Of The Provider | FREDERICK |
| View All |
Similar Doctors
|
|
Dr. Geung H. Ahn, MD |
|
|
Dr. Sanjay Kakar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Menke, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Annemieke Van Zante, MD |
|
|
Dr. Zohreh L. Tabatabai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward T. Sittler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhen Yan, MD
This Doctor is OpenDoctor Recommended.
|